Prasad Raju Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
3
Insider Sells Sum
$503,993.47

Insider Activity of Prasad Raju

According to the SEC Form 4 filings, Prasad Raju, being in a position of

  1. Chief Financial Officer at CRISPR Therapeutics AG,
    оver the last 12 months, has bought 0 shares, and sold 91777 shares for $5.3M,
    over all time since 2024-03-15, has bought 0 shares, and sold 101260 shares for $5.8M.

Biography of Prasad Raju

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $5,295,2886100

Comparison of Insiders on Amount of Buys and Sells

2026-03-23SaleCRISPR Therapeutics AG
CRSP
Chief Financial Officer
3,708
0.0039%
$46.78$173,460+12.37%
2026-03-16SaleCRISPR Therapeutics AG
CRSP
Chief Financial Officer
9,869
0.0102%
$48.26$476,278+8.26%
2026-01-22SaleCRISPR Therapeutics AG
CRSP
Chief Financial Officer
34,972
0.0363%
$60.19$2.1M-13.17%
2026-01-06SaleCRISPR Therapeutics AG
CRSP
Chief Financial Officer
29,700
0.037%
$60.16$1.79M-8.8%
2025-12-22SaleCRISPR Therapeutics AG
CRSP
Chief Financial Officer
10,000
0.011%
$55.95$559,549-8.15%
2025-12-22SaleCRISPR Therapeutics AG
CRSP
Chief Financial Officer
3,528
0.0038%
$55.10$194,401-8.15%
2025-03-21SaleCRISPR Therapeutics AG
CRSP
Chief Financial Officer
2,197
0.0026%
$41.23$90,582+30.35%
2025-03-17SaleCRISPR Therapeutics AG
CRSP
Chief Financial Officer
3,762
0.0043%
$41.80$157,252+25.39%
2024-03-15SaleCRISPR Therapeutics AG
CRSP
Chief Financial Officer
3,524
0.0042%
$72.69$256,160-32.16%
Total: 9
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.